Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia. | Prostate Int | 2023 | 37409096 | PubTator, text mining | PubMed |
| A harmonized resource of integrated prostate cancer clinical, -omic, and signature features. | Sci Data | 2023 | 37407670 | PubTator, text mining | PubMed |
| Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression. | Front Oncol | 2023 | 37404748 | PubTator, text mining | PubMed |
| Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | 37394580 | PubTator, text mining | PubMed |
| ASH1L-MRG15 methyltransferase deposits H3K4me3 and FACT for damage verification in nucleotide excision repair. | Nat Commun | 2023 | 37393406 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. | Anticancer Res | 2023 | 37351993 | PubTator, text mining | PubMed |
| A crucial role for dynamic expression of components encoding the negative arm of the circadian clock. | Nat Commun | 2023 | 37291101 | PubTator, text mining | PubMed |
| DECIPHER: Improving Genetic Diagnosis Through Dynamic Integration of Genomic and Clinical Data. | Annu Rev Genomics Hum Genet | 2023 | 37285546 | PubTator, text mining | PubMed |
| New molecular targets in Hodgkin and Reed-Sternberg cells. | Front Immunol | 2023 | 37266436 | PubTator, text mining | PubMed |
| Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation. | Cell Mol Immunol | 2023 | 37253946 | PubTator, text mining | PubMed |
| DNA damage repair proteins across the Tree of Life. | iScience | 2023 | 37250769 | PubTator, text mining | PubMed |
| The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis. | Mol Neurobiol | 2023 | 37243816 | PubTator, text mining | PubMed |
| Prognostic Values of Gene Copy Number Alterations in Prostate Cancer. | Genes (Basel) | 2023 | 37239316 | PubTator, text mining | PubMed |
| Recent advances in understanding DNA methylation of prostate cancer. | Front Oncol | 2023 | 37234978 | PubTator, text mining | PubMed |
| Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer. | Sci Rep | 2023 | 37231064 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case report. | J Immunother Cancer | 2023 | 37220954 | PubTator, text mining | PubMed |
| The interplay between viral molecular mimicry and host chromatin dynamics. | Nucleus | 2023 | 37218181 | PubTator, text mining | PubMed |
| Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37217462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=10